Skip to main content
TipRanks
Go Ultimate75% OFF

Sravan Kumar Emany Insider Profile

4 Followers

Sravan Kumar Emany, CFO at Beam Therapeutics, holds 0.00 shares in Assertio Therapeutics (Ticker: ASRT), holds 105.46K shares in Beam Therapeutics (Ticker: BEAM), holds 11.01K shares in Kyverna Therapeutics, Inc. (Ticker: KYTX).

Sravan Kumar Emany's Trading History

ASRT
Assertio Therapeutics
Jun 16, 2026―Uninformative Sell―$0.00
BEAM
Beam Therapeutics
Apr 02, 2026CFOUninformative Buy―$2.41M
KYTX
Kyverna Therapeutics, Inc.
Feb 26, 2026DirectorUninformative Buy―$55.58K
IRWD
Ironwood Pharma
Nov 20, 2024SVP, COO and CFOInformative Sell44.88K$1.50M

You May Also Like

Sravan Kumar Emany insider profile FAQ

What is the percentage of profitable transactions made by Sravan Kumar Emany?
The percentage of profitable transactions made by Sravan Kumar Emany is 50%.
What is the average return per transaction made by Sravan Kumar Emany?
The average return per transaction made by Sravan Kumar Emany is -17.70%.
What stocks does Sravan Kumar Emany hold?
Sravan Kumar Emany holds: BEAM, ASRT, IRWD, KYTX stocks.
What was Sravan Kumar Emany's most profitable transaction?
Sravan Kumar Emany’s most profitable transaction was an Informative Sell of IRWD stock on November 23, 2022. The return on the trade was 25.60%.
What is Sravan Kumar Emany's role in Beam Therapeutics?
Sravan Kumar Emany's role in Beam Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.